Enhanced surveillance of non-O157 verotoxin-producing Escherichia coli in human stool samples from Manitoba

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 16, Issue 6, 2005, Pages 329-334

  Thompson, Laura H ^a   Giercke, Sandra ^a   Beaudoin, Carole ^b   Woodward, David ^c   Wylie, John L ^a  

^a CADHAM PROVINCIAL LABORATORY   (Canada)

^b Manitoba Health   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

E coli; Epidemiology; Non O157; Surveillance; Verotoxin

Indexed keywords

VEROTOXIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CHILD; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE;

EID: 30644471717     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/859289     Document Type: Article

References (21)

1. Jelacic JK, Damrow T, Chen GS, et al. Shiga toxin-producing Escherichia coli in Montana: Bacterial genotypes and clinical profiles. J Infect Dis 2003;188:719-29.
2. Fey PD, Wickert RS, Rupp ME, Safranek TJ, Hinrichs SH. Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 2000;6:530-3.
3. Spika JS, Khakhria R, Michel P, Milley D, Wilson J, Waters J. Shiga toxin-producing Escherichia coli infections in Canada. In: Kaper JB, O'Brien AD, eds. Escherichia Coli O157: H7 and Other Shiga Toxin-Producing E coli Strains. Washington, DC: American Society Microbiology, 1998:23-9.
4. Blanco J, Blanco M, Blanco JE, et al. Verotoxin-producing Escherichia coli in Spain: Prevalence, serotypes, and virulence genes of O157:H7 and non-O157 VTEC in ruminants, raw beef products, and humans. Exp Biol Med (Maywood) 2003;228:345-51.
5. Eklund M, Leino K, Siitonen A. Clinical Escherichia coli strains carrying stx genes: Stx variants and stx-positive virulence profiles. J Clin Microbiol 2002;40:4585-93.
6. Dean-Nystrom EA, Melton-Celsa AR, Pohlenz JF, Moon HW, O'Brien AD. Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E coli strains in neonatal pigs. Infect Immun 2003;71:6526-33.
7. Milley DG, Sekla LH. An enzyme-linked immunosorbent assay-based isolation procedure for verotoxigenic Escherichia coli. Appl Environ Microbiol 1993;59:4223-9. (Erratum in 1994;60:1704).
8. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977;18:775-9.
9. Wang G, Clark CG, Rodgers FG. Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin family by multiplex PCR. J Clin Microbiol 2002;40:3613-9.
10. Gautom RK. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol 1997;35:2977-80.
11. SaTScan version 3.1. Software for the spatial and space-time scan statistics. 〈www.satscan.org〉 (Version current at November 1, 2005).
12. Cabral T, Jolly AM, Wylie JL. Chlamydia trachomatis omp1 genotypic diversity and concordance with sexual network data. J Infect Dis 2003;187:279-86.
13. Kulldorff M. A spatial scan statistic. Communications in Statistics - theory and methods 1997;26:1481-96.
14. Kulldorff M, Athas WF, Feurer EJ, Miller BA, Key CR. Evaluating cluster alarms: A space-time scan statistic and brain cancer in Los Alamos, New Mexico. Am J Public Health 1998;88:1377-80.
15. Woodward DL, Clark CG, Caldeira RA, Ahmed R, Rodgers FG. Verotoxigenic Escherichia coli (VTEC): A major public health threat in Canada. Can J Infect Dis 2002;13:321-30.
16. Hiruta N, Murase T, Okamura N. An outbreak of diarrhoea due to multiple antimicrobial-resistant Shiga toxin-producing Escherichia coli O26:H11 in a nursery. Epidemiol Infect 2001;127:221-7. (Erratum in 2002;128:355).
17. Werber D, Fruth A, Liesegang A, et al. A multistate outbreak of Shiga toxin-producing Escherichia coli O26:H11 infections in Germany, detected by molecular subtyping surveillance. J Infect Dis 2002;186:419-22.
18. Misselwitz J, Karch H, Bielazewska M, et al. Cluster of hemolyticuremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11. Pediatr Infect Dis J 2003;22:349-54.
19. Eklund M, Scheutz F, Siitonen A. Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: Serotypes, virulence characteristics, and molecular profiles of strains of the same serotype. J Clin Microbiol. 2001;39:2829-34.
20. Werber D, Fruth A, Buchholz U, et al. Strong association between shiga toxin-producing Escherichia coli Ol57 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome. Eur J Clin Microbiol Infect Dis 2003;22:726-30.
21. Khan A, Yamasaki S, Sato T, et al. Prevalence and genetic profiling of virulence determinants of non-O157 Shiga toxin-producing Escherichia coli isolated from cattle, beef, and humans, Calcutta, India. Emerg Infect Dis 2002;8:54-62.